Detalles de la búsqueda
1.
The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: analysis of individual patient data from IMvigor210 and IMvigor211 trials.
BJU Int
; 133(2): 158-168, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37422731
2.
Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer.
BJU Int
; 133(2): 214-222, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37803523
3.
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus.
World J Urol
; 42(1): 264, 2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38676733
4.
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy.
World J Urol
; 41(6): 1573-1579, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37148324
5.
Adjuvant immunotherapy in patients with high-risk muscle-invasive urothelial carcinoma: The potential impact of informative censoring.
Cancer
; 128(15): 2892-2897, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35553053
6.
Not All Adverse Pathology Features Are Equal: Identifying Optimal Candidates for Adjuvant Radiotherapy Among Patients With Adverse Pathology at Radical Prostatectomy.
J Urol
; 208(5): 1046-1055, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35830554
7.
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most?
World J Urol
; 40(11): 2667-2673, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36125505
8.
Von Hippel-Lindau disease-associated renal cell carcinoma: a call to action.
Curr Opin Urol
; 32(1): 31-39, 2022 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34783716
9.
Renal function outcomes in patients with muscle-invasive bladder cancer treated with neoadjuvant pembrolizumab and radical cystectomy in the PURE-01 study.
Int J Cancer
; 149(1): 186-190, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33720424
10.
Sequencing of PD-1/L1 Inhibitors and Carboplatin Based Chemotherapy for Cisplatin Ineligible Metastatic Urothelial Carcinoma.
J Urol
; 205(2): 414-419, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32935617
11.
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3).
World J Urol
; 39(9): 3407-3414, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33683412
12.
Identifying an optimal lymph node yield for penile squamous cell carcinoma: prognostic impact of surgical dissection.
BJU Int
; 125(1): 82-88, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31356716
13.
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma.
BJU Int
; 125(6): 867-875, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32175663
14.
Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center.
J Urol
; 199(3): 741-747, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28964782
15.
Impact of the Number of Cycles of Platinum Based First Line Chemotherapy for Advanced Urothelial Carcinoma.
J Urol
; 200(6): 1207-1214, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30012366
16.
First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study.
BJU Int
; 121(3): 348-356, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28921872
17.
Immunotherapy for metastatic urothelial carcinoma: status quo and the future.
Curr Opin Urol
; 28(1): 1-7, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29028766
18.
Nivolumab and its use in the second-line treatment of metastatic urothelial cancer.
Future Oncol
; 14(26): 2683-2690, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29927336
19.
Association of an aurora kinase a (AURKA) gene polymorphism with progression-free survival in patients with advanced urothelial carcinoma treated with the selective aurora kinase a inhibitor alisertib.
Invest New Drugs
; 35(4): 524-528, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28155045
20.
Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration.
J Urol
; 196(1): 95-100, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26748165